FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
The U.S. Food and Drug Administration (FDA) granted accelerated approval to tazemetostat for the treatment…
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Modern anti-cancer drugs work via tiny molecular motions
- Study examines role of biomarkers to evaluate kidney injury in cancer patients
- How genes and environment conspire in pancreatic cancer development discovered
- Researchers discover mechanism to overcome drug-resistance in leukaemia
- The OJC Episode 22: Disparity Special
- Does aspirin lower colorectal cancer risk in older adults? It depends on when they start
- Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients
- Better post-surgery care would dramatically improve cancer survival in LMICs
